90 related articles for article (PubMed ID: 30526604)
1. Aggressiveness of non-EMT breast cancer cells relies on FBXO11 activity.
Bagger SO; Hopkinson BM; Pandey DP; Bak M; Brydholm AV; Villadsen R; Helin K; Rønnov-Jessen L; Petersen OW; Kim J
Mol Cancer; 2018 Dec; 17(1):171. PubMed ID: 30526604
[TBL] [Abstract][Full Text] [Related]
2. FBXO11 promotes ubiquitination of the Snail family of transcription factors in cancer progression and epidermal development.
Jin Y; Shenoy AK; Doernberg S; Chen H; Luo H; Shen H; Lin T; Tarrash M; Cai Q; Hu X; Fiske R; Chen T; Wu L; Mohammed KA; Rottiers V; Lee SS; Lu J
Cancer Lett; 2015 Jun; 362(1):70-82. PubMed ID: 25827072
[TBL] [Abstract][Full Text] [Related]
3. F-box protein 11 promotes the growth and metastasis of gastric cancer via PI3K/AKT pathway-mediated EMT.
Sun C; Tao Y; Gao Y; Xia Y; Liu Y; Wang G; Gu Y
Biomed Pharmacother; 2018 Feb; 98():416-423. PubMed ID: 29278851
[TBL] [Abstract][Full Text] [Related]
4. MiRNA-621 sensitizes breast cancer to chemotherapy by suppressing FBXO11 and enhancing p53 activity.
Xue J; Chi Y; Chen Y; Huang S; Ye X; Niu J; Wang W; Pfeffer LM; Shao ZM; Wu ZH; Wu J
Oncogene; 2016 Jan; 35(4):448-58. PubMed ID: 25867061
[TBL] [Abstract][Full Text] [Related]
5. F-box proteins: Keeping the epithelial-to-mesenchymal transition (EMT) in check.
Díaz VM; de Herreros AG
Semin Cancer Biol; 2016 Feb; 36():71-9. PubMed ID: 26506454
[TBL] [Abstract][Full Text] [Related]
6. FBXO11 represses cellular response to hypoxia by destabilizing hypoxia-inducible factor-1α mRNA.
Ju UI; Park JW; Park HS; Kim SJ; Chun YS
Biochem Biophys Res Commun; 2015 Sep; 464(4):1008-1015. PubMed ID: 26187670
[TBL] [Abstract][Full Text] [Related]
7. The oncogenic microRNA-21 inhibits the tumor suppressive activity of FBXO11 to promote tumorigenesis.
Yang CH; Pfeffer SR; Sims M; Yue J; Wang Y; Linga VG; Paulus E; Davidoff AM; Pfeffer LM
J Biol Chem; 2015 Mar; 290(10):6037-46. PubMed ID: 25589783
[TBL] [Abstract][Full Text] [Related]
8. PKD1 phosphorylation-dependent degradation of SNAIL by SCF-FBXO11 regulates epithelial-mesenchymal transition and metastasis.
Zheng H; Shen M; Zha YL; Li W; Wei Y; Blanco MA; Ren G; Zhou T; Storz P; Wang HY; Kang Y
Cancer Cell; 2014 Sep; 26(3):358-373. PubMed ID: 25203322
[TBL] [Abstract][Full Text] [Related]
9. The ubiquitin ligase Siah is a novel regulator of Zeb1 in breast cancer.
Chen A; Wong CS; Liu MC; House CM; Sceneay J; Bowtell DD; Thompson EW; Möller A
Oncotarget; 2015 Jan; 6(2):862-73. PubMed ID: 25528765
[TBL] [Abstract][Full Text] [Related]
10. The dual role of FOXF2 in regulation of DNA replication and the epithelial-mesenchymal transition in breast cancer progression.
Lo PK; Lee JS; Liang X; Sukumar S
Cell Signal; 2016 Oct; 28(10):1502-19. PubMed ID: 27377963
[TBL] [Abstract][Full Text] [Related]
11. Ultrasound-targeted microbubble destruction-mediated silencing of FBXO11 suppresses development of pancreatic cancer.
Xue J; Chen S; Ge D; Yuan X
Hum Cell; 2022 Jul; 35(4):1174-1191. PubMed ID: 35437704
[TBL] [Abstract][Full Text] [Related]
12. The dual function of PRMT1 in modulating epithelial-mesenchymal transition and cellular senescence in breast cancer cells through regulation of ZEB1.
Gao Y; Zhao Y; Zhang J; Lu Y; Liu X; Geng P; Huang B; Zhang Y; Lu J
Sci Rep; 2016 Jan; 6():19874. PubMed ID: 26813495
[TBL] [Abstract][Full Text] [Related]
13. FBXW7 suppresses epithelial-mesenchymal transition, stemness and metastatic potential of cholangiocarcinoma cells.
Yang H; Lu X; Liu Z; Chen L; Xu Y; Wang Y; Wei G; Chen Y
Oncotarget; 2015 Mar; 6(8):6310-25. PubMed ID: 25749036
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1b Splice Variant Promotes αvβ3-mediated EMT Induced by LPS in Breast Cancer Cells.
Luo BP; Luo J; Hu YB; Yao XW; Wu FH
Curr Med Sci; 2018 Jun; 38(3):467-472. PubMed ID: 30074214
[TBL] [Abstract][Full Text] [Related]
15. The ubiquitin ligase COP1 regulates cell cycle and apoptosis by affecting p53 function in human breast cancer cell lines.
Ka WH; Cho SK; Chun BN; Byun SY; Ahn JC
Breast Cancer; 2018 Sep; 25(5):529-538. PubMed ID: 29516369
[TBL] [Abstract][Full Text] [Related]
16. The pan-inhibitor of Aurora kinases danusertib induces apoptosis and autophagy and suppresses epithelial-to-mesenchymal transition in human breast cancer cells.
Li JP; Yang YX; Liu QL; Zhou ZW; Pan ST; He ZX; Zhang X; Yang T; Pan SY; Duan W; He SM; Chen XW; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1027-62. PubMed ID: 25733818
[TBL] [Abstract][Full Text] [Related]
17. Bidirectional crosstalk between PD-L1 expression and epithelial to mesenchymal transition: significance in claudin-low breast cancer cells.
Alsuliman A; Colak D; Al-Harazi O; Fitwi H; Tulbah A; Al-Tweigeri T; Al-Alwan M; Ghebeh H
Mol Cancer; 2015 Aug; 14():149. PubMed ID: 26245467
[TBL] [Abstract][Full Text] [Related]
18. Functional cooperation of RKTG with p53 in tumorigenesis and epithelial-mesenchymal transition.
Jiang Y; Xie X; Li Z; Wang Z; Zhang Y; Ling ZQ; Pan Y; Wang Z; Chen Y
Cancer Res; 2011 Apr; 71(8):2959-68. PubMed ID: 21385899
[TBL] [Abstract][Full Text] [Related]
19. Leptin promotes epithelial-mesenchymal transition of breast cancer via the upregulation of pyruvate kinase M2.
Wei L; Li K; Pang X; Guo B; Su M; Huang Y; Wang N; Ji F; Zhong C; Yang J; Zhang Z; Jiang Y; Liu Y; Chen T
J Exp Clin Cancer Res; 2016 Oct; 35(1):166. PubMed ID: 27769315
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of SDF-1/CXCR4-induced epithelial-mesenchymal transition by kisspeptin-10.
Gründker C; Bauerschmitz G; Knapp J; Schmidt E; Olbrich T; Emons G
Breast Cancer Res Treat; 2015 Jul; 152(1):41-50. PubMed ID: 26062751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
